[Treatment of ulcer with a new antacid-antisecretive-antispastic combination].
D000328:Adult; D000863:Antacids / Q000627:therapeutic use*; D005260:Female; D005750:Gastric Juice / Q000378:metabolism; D005753:Gastric Mucosa / Q000378:metabolism; D005756:Gastritis / Q000188:drug therapy; D006634:Histamine H1 Antagonists / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010437:Peptic Ulcer / Q000188:drug therapy*; D012636:Secretory Rate / Q000187:drug effects
D000863:Antacids; D006634:Histamine H1 Antagonists; D010276:Parasympatholytics
Trattamento della malattia ulcerosa con una nuova associazione antiacida-antisecretiva-antispastica.